Vocabria 30 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vocabria 30 mg compresse rivestite con film

viiv healthcare gmbh - cabotegravirum - compresse rivestite con film - cabotegravirum 30 mg ut cabotegravirum natricum, lactosum monohydricum 163.59 mg, cellulosum microcristallinum, hypromellosum, carboxymethylamylum natricum a, magnesii stearas, Überzug: hypromellosum e 171, macrogolum 400, pro compresso obducto corresp. natrium 2.67 - 3.59 mg. - l'infezione da hiv - synthetika

Apretude Unione Europea - italiano - EMA (European Medicines Agency)

apretude

viiv healthcare b.v. - cabotegravir - infezioni da hiv - antivirali per uso sistemico - apretude is indicated in combination with safer sex practices for pre-exposure prophylaxis (prep) to reduce the risk of sexually acquired hiv-1 infection in high-risk adults and adolescents, weighing at least 35 kg (see sections 4. 2, 4. 4 e 5.

Vocabria Unione Europea - italiano - EMA (European Medicines Agency)

vocabria

viiv healthcare b.v. - cabotegavir sodium, cabotegravir - infezioni da hiv - antivirali per uso sistemico - vocabria tablets are indicated in combination with rilpivirine tablets for the short-term treatment of human immunodeficiency virus type 1 (hiv-1) infection in adults who are virologically suppressed (hiv-1 rna.

Vocabria 400 mg / 2 ml Deposito-Injektionssuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vocabria 400 mg / 2 ml deposito-injektionssuspension

viiv healthcare gmbh - cabotegravirum - deposito-injektionssuspension - cabotegravirum 400 mg, mannitolum, polysorbatum 20, macrogolum 3350, aqua ad iniectabile, ad solutionem pro 2 ml. - l'infezione da hiv - synthetika

Vocabria 600 mg / 3 ml Deposito-Injektionssuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

vocabria 600 mg / 3 ml deposito-injektionssuspension

viiv healthcare gmbh - cabotegravirum - deposito-injektionssuspension - cabotegravirum 600 mg, mannitolum, polysorbatum 20, macrogolum 3350, aqua ad iniectabile, ad solutionem pro 3 ml. - l'infezione da hiv - synthetika

Rekambys Unione Europea - italiano - EMA (European Medicines Agency)

rekambys

janssen-cilag international nv - rilpivirine - infezioni da hiv - antivirali per uso sistemico - rekambys is indicated, in combination with cabotegravir injection, for the treatment of human immunodeficiency virus type 1 (hiv 1) infection in adults who are virologically suppressed (hiv-1 rna < 50 copies/ml) on a stable antiretroviral regimen without present or past evidence of viral resistance to, and no prior virological failure with, agents of the nnrti and ini class.

REKAMBYS 600 mg / 2 ml Deposito-Injektionssuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

rekambys 600 mg / 2 ml deposito-injektionssuspension

janssen-cilag ag - rilpivirinum - deposito-injektionssuspension - rilpivirinum 600 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 2 ml corresp. natrium 1.66 mg. - l'infezione da hiv - synthetika

REKAMBYS 900 mg / 3 ml Deposito-Injektionssuspension Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

rekambys 900 mg / 3 ml deposito-injektionssuspension

janssen-cilag ag - rilpivirinum - deposito-injektionssuspension - rilpivirinum 900 mg, poloxamerum 338, glucosum monohydricum, natrii dihydrogenophosphas monohydricus, acidum citricum monohydricum, natrii hydroxidum, aqua ad iniectabile q.s. ad suspensionem pro 3 ml corresp. natrium 2.49 mg. - l'infezione da hiv - synthetika

Isentress 400 mg Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

isentress 400 mg compresse rivestite con film

msd merck sharp & dohme ag - raltegravirum - compresse rivestite con film - raltegravirum 400 mg ut raltegravirum kalicum, cellulosum microcristallinum, lactosum monohydricum 26.1 mg, dikalii phosphas anhydricus, hypromellosum, poloxamerum 407, natrii stearylis fumaras, magnesii stearas, e 321, Überzug: poly(alcohol vinylicus), macrogolum 3350, talcum, e 171, e 172 (rubrum), e 172 (nigrum), pro compresso obducto corresp. natrium 510 µg. - le infezioni da hiv - synthetika

Isentress 25 mg Compresse masticabili Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

isentress 25 mg compresse masticabili

msd merck sharp & dohme ag - raltegravirum - compresse masticabili - raltegravirum 25 mg ut raltegravirum kalicum, hydroxypropylcellulosum, sucralosum, saccharinum natricum, natrii citras dihydricus, mannitolum, ammonii glycyrrhizas corresp. fructosum 0.54 mg et sorbitolum 1.47 mg, crospovidonum, magnesii stearas, natrii stearylis fumaras, ethylcellulosum, triglycerida media, acidum oleicum, Überzug: hypromellosum, macrogolum 400, e 172 (flavum), aromatica bananenaroma corresp. saccharum 3.5 mg, aromatica orangenaroma, aromatica maskierungsaroma corresp. saccharum 3.5 mg et aspartamum 0.47 mg, pro compresso corresp. natrium 1.19 mg. - l'infezione da hiv - synthetika